

Health AI Startup Investing | Syndicate & Venture Fund | Alumni Ventures
Investing at the intersection of AI, healthcare, and human health.
What It Is
A private investment community, syndicate, and fund backing visionary founders at the intersection of artificial intelligence, healthcare, and human health. As AI advances toward superintelligence, we believe this convergence represents one of the most profound opportunities to create enduring enterprise value and advance human potential. We invest in companies rebuilding healthcare’s intelligent infrastructure, reimagining how we understand and manage health and deliver care, and unlocking new frontiers in science and medicine. Through a diversified fund and selective deal-by-deal syndications, members gain access to high-potential ventures alongside leading venture capital firms, with accessible minimums and shared investment diligence.
Who It Is For
Accredited and qualified investors who believe artificial intelligence will fundamentally reshape healthcare and expand the boundaries of human health, creating one of the most compelling investment opportunities of our generation. A great fit for those who recognize the extraordinary potential of AI to reinvent a multitrillion-dollar industry, reimagine health and care, accelerate scientific discovery, and unlock entirely new markets. Designed for investors seeking curated access to transformative companies, broad diversification, and the opportunity to invest alongside leading venture capital firms and a community of like-minded investors.
Take 5 seconds. No document uploads.
It’s All About Access to Cutting-Edge Deals
You Get Access to Deals Led by Brand Name VC Firms: Quantity, Diversification.
Customize Your Venture Portfolio
Build a venture portfolio to fit your goals. Alumni Ventures invests across stages and geographies, co-investing with elite firms.
- Home
Pre-seed to Later-Stage
We invest at a variety of stages, always evaluating upside vs. price. - Home
Diverse Geographies + Leads
We look for great deals everywhere and co-invest alongside a wide variety of strong lead VC firms. - Home
Due Diligence by Alumni Ventures
America's Largest Venture Firm for Individuals and an “America’s Top 20 Venture Capital Firm of 2025” (Time ’25). - Home
Favorite Sectors? We’ve got you Covered
Interested in Medicine 3.0? Strategic Tech? Women’s Founders? Early Stage AI Deals? Customize the fund and deals you want to see and add your portfolio - Home
You Decide
Invest in funds for maximum coverage. Invest deal-by-deal for maximum exposure.
Co-Invest With Elite VCs
These firms have co-invested in many deals with Alumni Ventures:
- Home
Andreessen Horowitz
51 investments with AV - Home
Sequoia
25 investments with AV - Home
Bessemer Venture Partners
22 investments with AV - Home
Y Combinator
56 investments with AV - Home
Founders Fund
28 investments with AV - Home
Kleiner Perkins
23 investments with AV - Home
Khosla Ventures
56 investments with AV
Co-investors shown for illustrative purposes only, are not indicative of all organizations with which AV co-investors, and do not necessarily indicate future co-investors. The identity of a co-investor is not a guarantee of investment quality or performance.
Getting Started with Us
How You Want to Partner With Us Is Up to You.
Our Fund
*Diversification may help mitigate risk but cannot ensure a profit or protect against loss in a declining market.
- Home
A Simple Way to A Startup Portfolio
An annual fund of ~20-30 high-quality diversified investments — offering you an most efficient way to build a large portfolio. - Home
Diversification Across Many Dimensions
Diversification across sector, stage, geography, and lead investor — which may help mitigate risk, while seeking the potential upside.* - Home
Leave It up to Us
Our team gets up every day to strategically deploy your capital over ~12-18 months, reserving ~20% to pursue follow-on opportunities in promising portfolio investments.
Our Syndicate
These are single asset investments that are not diversified.
- Home
Real-Time Deal Flow
You see deals as we see them - about a deal a month (it ebbs and flows). Deals move fast and sometimes fill up. - Home
Access to Our Diligence Portal
Access due diligence and view "Why We Are Investing" video briefs. - Home
Hands-On Capital Management
You decide which investment opportunities are right for you and how much to invest.
Timeline for the Annual Health AI Fund


Take 5 seconds. No document uploads.
About Alumni Ventures
- Home
Renowned-Industry Recognition and Battle Tested
PitchBook names AV as U.S. Top 3 Most Active VC (2018–2025) and CB Insights slots us in its 2024 Top 20; Top-Decile DPI Investment Performance* - Home
Diversification From Day One
$1.6B+ total capital raised across 1,800+ companies, with ~250-300 new investments added annually; diversification may help spread risk and upside across stage, sector, and geography. - Home
Co-Investing With the Established Firms
AV routinely co-invests alongside leading venture firms such as Andreessen Horowitz, Sequoia, and NEA, and AV funds invests at the same price as those firms, although non-price terms may differ. - Home
Network You Can Lean On
25,000 investors and syndicate members — along with an 850,000-strong community* — create proprietary deal flow, talent pipelines, and follow-on capital impossible to assemble alone. - Home
Dedicated, Nationwide Team
~40 full-time venture professionals spread across seven U.S. offices source ~50-75 fresh opportunities each quarter, vet them rigorously, and present only the deals we commit to doing for our funds.
For more information regarding our awards and recognition see here
For more on performance see here
*Community size is the sum of investors, social media followers, and people opted-into AV marketing.
*Performance data is from Cambridge Associates Venture Benchmarks and is as of 06/30/25. Industry Top Quartile as determined by Cambridge Associates. Distributions to Paid-In Capital (DPI) for AV Funds and Industry Top Quartile is net of management fees and net of incentive allocations applied to amounts distributed to investors. For additional information on Cambridge Associates and the data and calculations see av-funds.com/disclosures.
See video policy below.
Meet the Team
- Fund Team
- Scouts
- AV Support Team
Health AI Content & News
Content at the intersection of entrepreneurship, venture capital, and specific industry sectors.
Health AI Fund Portfolio
We invest alongside other established venture firms in a broad range of ventures to help build you a diversified venture fund.
- 3X Genetics
- Adora
- Alli Connect
- Alloy Therapeutics
- American Gene Technologies
- Amigo
- Andromeda Surgical
- Assort Health
- Baton Health
- Beacon Biosignals
- Bionaut Labs
- Bionic Health
- Brave Health
- Cartwheel
- Centaur Health Holdings
- Concerto Biosciences
- Dimension Bio
- Dropstat
- Earli
- eddii
- Emm
- Ezra
- Flagler Health
- Generate Biomedicines
- Genetesis
- Gyde
- HelixNano
- Hello Patient
- Hepta Bio
- Hopscotch Health
- Jona
- Juvena Therapeutics
- Kanvas Biosciences
- Karoo Health
- Koala
- Lila Sciences
- Mending
- Miga Health
- Mign
- Nectero Medical
- Nest Health
- Nextiles
- Peer
- Pi Health
- Q Bio
- Rook
- Sage
- Sami
- Satellite Bio
- SiPhox
- Slope
- Spiras Health
- Sully
- TFC Therapeutics
- Tiny Health
- Torch Technology
- Upside Health
- VenoStent
- Zus Health
Portfolio companies are shown for illustrative purposes only; not necessarily indicative of any AV fund or investor. Investments shown are not available to future investors, except potentially in the case of follow-on investments. Past performance does not guarantee future results.
Interested in Seeing Curated Venture Deals?
Sign up and receive a $50 credit to the AV Swag Store, full of high-end men’s and women’s apparel and accessories.
- Home
Easy Sign-Up
Click a button. 5 seconds. - Home
No Obligation to Invest
Only invest in deals you like. - Home
Co-Invest Alongside Leading VCs
Frequent co-investors include a16z, Sequoia, Khosla, Accel, and more. - Home
Deal Transparency
Due Diligence and Investment Memos provided. Live Deal discussions with our investment teams.










